Covid Inquiry: Former chief medical officer close to tears over pandemic deaths
Dame Sally Davies apologises to bereaved families and says the UK was poorly prepared for the pandemic.
Similar Posts
6 Stupid Holiday Food ‘Rules’ That Are Really Diets In Disguise
It’s the most wonderful time of the year ― unless you’re on a diet and have set impossible standards for eating during the holidays. There’s nothing wrong with taking an “everything in moderation” approach at the dinner table, but other “rules” we establish for ourselves around the holidays can actually hinder rather than help our…
Matt Hancock says UK’s pandemic strategy was completely wrong
Planning focused more on burying the dead than averting disaster, ex-health secretary says.
Scientists Find About A Quarter Million Nanoplastic Particles In Bottled Water
The average liter of bottled water has nearly a quarter million invisible pieces of ever so tiny nanoplastics, detected and categorized for the first time by a microscope using dual lasers. Scientists long figured there were lots of these microscopic plastic pieces, but until researchers at Columbia and Rutgers universities did their calculations they never…
Sleep tracking going too far? You might be suffering from this condition, expert says
The duration and quality of sleep are both essential to overall health, experts agree — but when does a focus on getting a good night’s sleep turn into a harmful fixation? For some people, checking the data on their wearable sleep trackers can lead to a condition called “orthosomnia,” a name the Journal of Clinical…
Scientists crack mystery of how MS gene spread
The DNA of ancient cattle herders has revealed how diseases evolved in Europe over thousands of years.
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…
